Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 281
Filter
1.
J Int Med Res ; 51(4): 3000605231158015, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37062969

ABSTRACT

Congenital systemic candidiasis is a rare disease observed in both full-term and preterm infants. It can occur with or without congenital cutaneous candidiasis (CCC) and to date, only a few cases have been reported in the literature. We report here, a case of a full-term newborn who presented with diffuse skin eruptions at birth. Blood, urine, and skin scraping cultures were positive and the aetiological agent was Candida albicans. After six weeks of anti-fungal treatment with fluconazole, the newborn was cured. Early diagnosis is crucial in preventing complications caused by candidiasis in newborns.


Subject(s)
Candidiasis, Cutaneous , Candidiasis , Infant, Newborn , Humans , Infant , Infant, Premature , Candidiasis/diagnosis , Candidiasis/drug therapy , Candidiasis/etiology , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/complications , Fluconazole/therapeutic use , Skin , Antifungal Agents/therapeutic use
3.
Pediatr Dermatol ; 39(6): 952-954, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35879203

ABSTRACT

We present a case of a full-term neonate born with respiratory distress and a widespread erythematous rash, who was found to have congenital cutaneous candidiasis (CCC). The significance of this report is to contribute to the pre-existing literature on the rarity of CCC, but also to share a case of a patient who was successfully treated conservatively with topical antifungal agents only.


Subject(s)
Candidiasis, Cutaneous , Exanthema , Infant, Newborn, Diseases , Infant, Newborn , Humans , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/congenital , Skin , Infant, Newborn, Diseases/drug therapy , Exanthema/drug therapy , Antifungal Agents/therapeutic use
4.
Bol. malariol. salud ambient ; 61(3): 391-400, ago. 2021. tab., ilus.
Article in Spanish | LILACS, LIVECS | ID: biblio-1400103

ABSTRACT

La candidiasis es una enfermedad micótica debida a levaduras pertenecientes al género Candida. Dentro del gran conjunto de microorganismos que colonizan al ser humano, Candida albicans es el agente etiológico más comúnmente detectado ya que habita como comensal en las superficies mucosas y la piel. C. albicans participa en procesos de fermentación de azúcares y asimilación de nutrientes, pero, en algunas ocasiones se relaciona con procesos patológicos. En los últimos años los avances tecnológicos y médicos; así como el aumento en la incidencia de infecciones por el virus de la inmunodeficiencia humana, el auge creciente de la terapia inmunomoduladora y el uso de antibióticos de amplio espectro durante largos períodos de tiempo se han convertido en los factores de riesgo más importantes para la creciente incidencia de infecciones por microorganismos del género Candida. Debido a esto, resulta imperativo el conocimiento de esta enfermedad y sus formas clínicas más importantes, así como el abordaje diagnóstico y el tratamiento actual; información que recolectamos en este documento para brindar una visión general sobre esta patología(AU)


Candidiasis is a fungal disease caused by yeasts belonging to the genus Candida. Within the large group of microorganisms that colonize humans, candida albicans is the most commonly detected etiological agent since it inhabits mucosal surfaces and skin as a commensal. C. albicans participates in sugar fermentation processes and assimilation of nutrients but, on some occasions, it is related to pathological processes. In recent years, technological and medical advances; As well as the increase in the incidence of human immunodeficiency virus infections, the growing boom in immunomodulatory therapy and the use of broad-spectrum antibiotics for long periods of time have become the most important risk factors for the increasing incidence of infections by microorganisms of the genus Candida. Due to this, knowledge of this disease and its most important clinical forms, as well as the current diagnostic approach and treatment, is imperative; information that we collect in this document to provide an overview of this condition(AU)


Subject(s)
Humans , Candidiasis/etiology , Candidiasis, Cutaneous/diagnosis , Candidiasis, Vulvovaginal/diagnosis , Risk Factors , Candida albicans , Incidence , Esophagitis , Immunomodulation
5.
Pan Afr Med J ; 38: 178, 2021.
Article in English | MEDLINE | ID: mdl-33995784

ABSTRACT

Candidiasis is an acute or subacute fungal infection caused by fungi that belongs to candida genus, with Candida albicansbeing the most frequent causative agent. Candida kefyr is a rare cause of candidiasis which has been reported in systemic candidiasis and deep infections. However, to date, it has never been reported as a cause in dermatophytosis. We report a case of candidiasis caused by Candida kefyr in a 72-year-old woman with a chief complaint of pruritic erythematous rash on the back from one day prior to admission. Diagnosis was established based on clinical features, direct microscopic examination with 10% potassium hydroxide solution, gram staining. The fungal species was determined by carbohydrate fermentation test which showed a positive result for Candida kefyr. The patient was treated with miconazole cream and fusidic cream and showed significant clinical improvement.


Subject(s)
Antifungal Agents/administration & dosage , Candidiasis, Cutaneous/diagnosis , Kluyveromyces/isolation & purification , Aged , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/microbiology , Erythema/microbiology , Female , Fusidic Acid/administration & dosage , Humans , Miconazole/administration & dosage , Pruritus/microbiology , Treatment Outcome
6.
Pediatr Infect Dis J ; 40(6): e230-e233, 2021 06 01.
Article in English | MEDLINE | ID: mdl-33538540

ABSTRACT

Congenital cutaneous candidiasis is an infrequent invasive fungal infection that usually appears in the first days of life. Extremely low birth weight infants are the most frequently affected. Classic presentation includes diffuse extensive erythematous rash with papules, plaques, pustules and vesicles, which later undergoes desquamation. Systemic dissemination is common in extremely low birth weight infants. Blood, urine and cerebrospinal fluid evaluation should be included in the initial assessment. Early and prolonged treatment has been associated with decreased mortality. We report the case of congenital cutaneous candidiasis in a preterm infant. Early skin lesion recognition allowed establishing adequate treatment in the first hours of life.


Subject(s)
Candidiasis, Cutaneous/congenital , Candidiasis, Cutaneous/diagnosis , Skin/pathology , Antifungal Agents/therapeutic use , Candidiasis, Cutaneous/blood , Candidiasis, Cutaneous/drug therapy , Female , Humans , Infant, Extremely Low Birth Weight , Infant, Newborn , Skin/microbiology , Treatment Outcome
8.
Rev Iberoam Micol ; 37(2): 68-71, 2020.
Article in English | MEDLINE | ID: mdl-32493666

ABSTRACT

BACKGROUND: Cutaneous congenital candidiasis (CCC) is a rare condition consisting of invasive fungal infection of the epidermis and dermis that mostly affects preterm infants. Maternal vaginal candidiasis is present in half of the cases, although the occurrence of invasive candidiasis during pregnancy or peripartum period is exceptional. CASE REPORT: We present the case of a full-term infant that was born by vacuum-assisted vaginal delivery to an apparently healthy 33 year-old woman with no history of intravenous drug use or vaginal candidiasis during pregnancy. The newborn showed a diffuse maculopapular rash with respiratory distress and bilateral interstitial lung infiltrates, requiring nasal continuous positive airway pressure support. Blood cultures obtained from the mother due to intrapartum fever yielded Candida albicans. Cultures of vaginal discharge and neonate skin also yielded C. albicans with the same in vitro susceptibly pattern. No alternative source for candidemia was identified. The clinical course after starting a systemic antifungal therapy was favorable in both the mother and the neonate, with clearance of candidemia and resolution of the skin lesions. CONCLUSIONS: CCC must be considered in full-term newborns with maculopapular rash at birth or during the first days of life. The absence of alternative sources for bloodstream infection in the present case suggests a potential etiopathogenic relationship between CCC and maternal candidemia. It is reasonable to rule out postpartum candidemia when CCC is suspected.


Subject(s)
Candidemia/microbiology , Candidiasis, Cutaneous/congenital , Candidiasis, Vulvovaginal/microbiology , Infectious Disease Transmission, Vertical , Pregnancy Complications, Infectious/microbiology , Adult , Antifungal Agents/therapeutic use , Candidemia/drug therapy , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/transmission , Candidiasis, Vulvovaginal/drug therapy , Continuous Positive Airway Pressure , Female , Humans , Infant, Newborn , Lung Diseases, Fungal/congenital , Lung Diseases, Fungal/drug therapy , Lung Diseases, Fungal/therapy , Maternal-Fetal Exchange , Pregnancy , Pregnancy Complications, Infectious/drug therapy , Puerperal Disorders/drug therapy , Puerperal Disorders/microbiology , Vacuum Extraction, Obstetrical
9.
Rev. iberoam. micol ; 37(2): 68-71, abr.-jun. 2020. ilus
Article in English | IBECS | ID: ibc-199135

ABSTRACT

BACKGROUND: Cutaneous congenital candidiasis (CCC) is a rare condition consisting of invasive fungal infection of the epidermis and dermis that mostly affects preterm infants. Maternal vaginal candidiasis is present in half of the cases, although the occurrence of invasive candidiasis during pregnancy or peripartum period is exceptional. CASE REPORT: We present the case of a full-term infant that was born by vacuum-assisted vaginal delivery to an apparently healthy 33 year-old woman with no history of intravenous drug use or vaginal candidiasis during pregnancy. The newborn showed a diffuse maculopapular rash with respiratory distress and bilateral interstitial lung infiltrates, requiring nasal continuous positive airway pressure support. Blood cultures obtained from the mother due to intrapartum fever yielded Candida albicans. Cultures of vaginal discharge and neonate skin also yielded C. albicans with the same in vitro susceptibly pattern. No alternative source for candidemia was identified. The clinical course after starting a systemic antifungal therapy was favorable in both the mother and the neonate, with clearance of candidemia and resolution of the skin lesions. CONCLUSIONS: CCC must be considered in full-term newborns with maculopapular rash at birth or during the first days of life. The absence of alternative sources for bloodstream infection in the present case suggests a potential etiopathogenic relationship between CCC and maternal candidemia. It is reasonable to rule out postpartum candidemia when CCC is suspected


ANTECEDENTES: La candidiasis congénita cutánea (CCC) es una entidad infrecuente que consiste en una infección invasiva de la epidermis y dermis, fundamentalmente en neonatos pretérmino. La candidiasis vaginal materna puede estar presente en la mitad de los casos, si bien el desarrollo de candidiasis invasiva durante el embarazo o el periodo post-parto es excepcional. CASO CLÍNICO: Presentamos el caso de un recién nacido a término mediante parto vaginal asistido con ventosa de una mujer de 33 años aparentemente sana y en la que no se recogían antecedentes de uso de drogas por vía parenteral o candidiasis vaginal durante el embarazo. El neonato presentaba un exantema maculopapular difuso asociado a dificultad respiratoria e infiltrados pulmonares intersticiales bilaterales, por lo que precisó de soporte ventilatorio con presión positiva nasal contínua. Los hemocultivos realizados a partir de muestras de sangre de la madre debido a la presencia de fiebre intraparto fueron positivos para Candida albicans. Los cultivos de secreción vaginal y de la piel del neonato también revelaron C. albicans con idéntico perfil de sensibilidad in vitro. No se identificó ninguna fuente alternativa de candidemia. La evolución clínica fue favorable tanto en la madre como en el recién nacido tras el inicio de un tratamiento antifúngico, con aclaramiento de la candidemia y resolución de las lesiones cutáneas. CONCLUSIONES: El diagnóstico de CCC debe ser considerado en el recién nacido a término con exantema maculopapular al nacimiento o en los primeros días de vida. La ausencia de un origen alternativo de infección en nuestro caso sugiere una asociación etiopatogénica potencial entre la CCC y la candidemia materna. En escenarios sugerentes de CCC resulta razonable descartar la presencia de candidemia materna en el periodo post-parto


Subject(s)
Humans , Male , Female , Infant, Newborn , Adult , Candidiasis, Cutaneous/congenital , Candidiasis, Cutaneous/microbiology , Candida albicans/isolation & purification , Pregnancy Complications, Parasitic , Infant, Newborn, Diseases/microbiology , Candidiasis, Cutaneous/diagnosis
11.
J Dermatol ; 47(4): 385-389, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32030818

ABSTRACT

Anogenital skin care for the elderly remains an umbrella term concerning protective and non-interventional regimens, particularly for ordinary diaper users. Our recent investigation has demonstrated the preventive effect of daily anogenital washing with miconazole nitrate-containing soap to the development of diaper candidiasis. We extended this work to cover our hypothesis as to whether the miconazole soap has a therapeutic benefit in genital candidiasis. The study outline includes: (i) the enrollment of 21 bedridden inpatients (84 ± 9 years; eight men and 13 women) who were diagnosed clinically and mycologically with genital candidiasis, and who had never received topical and/or systemic antifungal agents; (ii) administration of anogenital washing with 0.75% miconazole-containing soap once daily for 4 weeks; and (iii) assessment of clinical symptoms and detection of Candida materials by culture and microscopic examination. As assessed by clinical symptom scoring for incontinence-associated dermatitis (IAD), the ratio of patients with severe to moderate symptoms dramatically decreased by 2 weeks and 10 of 21 patients became symptom-free at 4 weeks. The IAD clinical severity score was significantly decreased at 4 weeks. Compared with the baseline positivity, both microscopic and cultured Candida-positive rates were significantly decreased at 4 weeks after washing. All culture-detected fungi were Candida albicans. Severe adverse events did not occur in all participants. Individual medical and risk factors had no significant correlation with clinical severity and duration of candidiasis on variance analysis. In conclusion, topical washing with miconazole soap is a safe and reliable non-medical approach for soothing diaper-associated genital candidiasis in bedridden inpatients in whom it is difficult to perform prompt medical examination.


Subject(s)
Antifungal Agents/administration & dosage , Candidiasis, Cutaneous/therapy , Candidiasis, Vulvovaginal/therapy , Diaper Rash/therapy , Skin Care/methods , Soaps/therapeutic use , Aged , Aged, 80 and over , Candida/isolation & purification , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/microbiology , Candidiasis, Vulvovaginal/diagnosis , Candidiasis, Vulvovaginal/microbiology , Diaper Rash/diagnosis , Diaper Rash/microbiology , Diapers, Adult/adverse effects , Female , Humans , Male , Miconazole/administration & dosage , Prospective Studies , Severity of Illness Index , Soaps/chemistry , Treatment Outcome , Urinary Incontinence/therapy
13.
Adv Neonatal Care ; 19(6): E3-E10, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31246615

ABSTRACT

BACKGROUND: Despite availability of rapid fungal potassium hydroxide (KOH) tests, many care providers rely on visual assessment to determine the diagnosis of monilial diaper dermatitis (MDD). PURPOSE: To determine whether a KOH test, when MDD is suspected, would result in more accurate diagnoses, with decreased antifungal medication prescription and exposure. METHODS: Quality improvement project from 2016 through 2017 with protocol implemented in 2017 for treatment of MDD after positive KOH testing. If monilial rash suspected, after 2 negative KOH tests, then antifungal ordered (considered false negative). χ testing and cost determination were performed. SAMPLE: Neonates in 2 level III neonatal intensive care units. OUTCOME VARIABLES: KOH test results, use of antifungal medication, and cost. RESULTS: The patient census included 1051 and 1015 patients in the year before and after the protocol initiation. The medical orders for antifungal medication decreased from 143 to 36 (P < .001; 95% odds ratio confidence interval, 2.24-4.38). There was a 75% reduction in both use and cost, as charged, of antifungal agents. Overall charges, including KOH test costs, decreased by 12%. Three infants received multiple negative KOH tests, then a positive one. These met the definition of false-negative tests, per protocol. There were no cases of fungal sepsis. IMPLICATIONS FOR PRACTICE: Use of a quality improvement protocol, in which the use of KOH testing is required, before antifungal agents are prescribed, results in decreased exposure and costs. IMPLICATIONS FOR RESEARCH: To test the feasibility of bedside "point-of-care" KOH testing, and whether KOH testing and reduced antifungal medication use affects antimicrobial resistance or invasive fungal sepsis.


Subject(s)
Antifungal Agents , Candidiasis, Cutaneous , Diaper Rash , Hydroxides/pharmacology , Medical Overuse , Potassium Compounds/pharmacology , Antifungal Agents/economics , Antifungal Agents/therapeutic use , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/etiology , Cost-Benefit Analysis , Diaper Rash/diagnosis , Diaper Rash/microbiology , Diaper Rash/prevention & control , Female , Humans , Indicators and Reagents/pharmacology , Infant, Newborn , Male , Medical Overuse/economics , Medical Overuse/prevention & control , Mycology/methods , Quality Improvement
15.
J Am Acad Dermatol ; 80(4): 869-880.e5, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30102951

ABSTRACT

Angioinvasive fungal infections cause significant morbidity and mortality because of their propensity to invade blood vessel walls, resulting in catastrophic tissue ischemia, infarct, and necrosis. While occasionally seen in immunocompetent hosts, opportunistic fungi are emerging in immunosuppressed hosts, including patients with hematologic malignancy, AIDS, organ transplant, and poorly controlled diabetes mellitus. The widespread use of antifungal prophylaxis has led to an "arms race" of emerging fungal resistance patterns. As the at-risk population expands and new antifungal resistance patterns develop, it is critical for dermatologists to understand and recognize angioinvasive fungal pathogens, because they are often the first to encounter the cutaneous manifestations of these diseases. Rapid clinical recognition, histopathologic, and culture confirmation can help render a timely, accurate diagnosis to ensure immediate medical and surgical intervention. Superficial dermatophyte infections and deep fungal infections, such as blastomycosis and histoplasmosis, have been well characterized within the dermatologic literature, and therefore this article will focus on the severe infections acquired by angioinvasive fungal species, including an update on new and emerging pathogens. In the first article in this continuing medical education series, we review the epidemiology and cutaneous manifestations. The second article in the series focuses on diagnosis, treatment, and complications of these infections.


Subject(s)
Dermatomycoses/pathology , Skin/blood supply , Aspergillosis/complications , Aspergillosis/diagnosis , Aspergillosis/epidemiology , Aspergillosis/pathology , Blood Vessels/pathology , Candidiasis, Cutaneous/complications , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/epidemiology , Candidiasis, Cutaneous/pathology , Dermatomycoses/complications , Dermatomycoses/diagnosis , Dermatomycoses/epidemiology , Drug Resistance, Fungal , Humans , Mucormycosis/complications , Mucormycosis/diagnosis , Mucormycosis/epidemiology , Mucormycosis/pathology , Opportunistic Infections/complications , Opportunistic Infections/diagnosis , Opportunistic Infections/epidemiology , Opportunistic Infections/pathology , Phaeohyphomycosis/complications , Phaeohyphomycosis/diagnosis , Phaeohyphomycosis/epidemiology , Phaeohyphomycosis/pathology
16.
Am J Dermatopathol ; 40(10): e138-e141, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29742560

ABSTRACT

Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis that typically results from mutations of the GJB2 gene or, less commonly, the GJB6 gene. Patients with KID syndrome are at higher risk of malignancy and infections. Here, we present 2 patients with KID syndrome who developed verrucous plaques. Given that patients with KID syndrome are at high risk of developing squamous cell carcinoma, biopsies were performed. Both cases revealed histologic findings of marked papillomatous epidermal hyperplasia with numerous fungal spores and pseudohyphae in the stratum corneum. For one case, daily oral fluconazole was initiated. The patient demonstrated dramatic resolution of his foot plaques over the course of 2 years. These cases highlight that, for the dermatopathologist, chronic fungal infection should be sought for verrucous plaques in patients with KID syndrome as, if present, this finding may alter treatment and quality of life.


Subject(s)
Candidiasis, Cutaneous/microbiology , Keratitis/complications , Skin/microbiology , Administration, Oral , Adolescent , Adult , Antifungal Agents/administration & dosage , Biopsy , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/drug therapy , Chronic Disease , Connexin 26 , Connexins/genetics , Female , Fluconazole/administration & dosage , Genetic Predisposition to Disease , Humans , Keratitis/diagnosis , Keratitis/genetics , Male , Mutation , Phenotype , Remission Induction , Skin/drug effects , Skin/pathology , Time Factors , Treatment Outcome
17.
Dermatol Online J ; 24(8)2018 Aug 15.
Article in English | MEDLINE | ID: mdl-30677843

ABSTRACT

Erosio interdigitalis blastomycetica (EIB) is a Candida infection affecting the third web space, between the third and fourth fingers. In 1915, Gougerot and Goncea first described saccharomycetic organisms isolated from the hands and feet. Johannes Fabry later named it in 1917, well before the genus Candida was introduced in 1923. EIB is most common among those who work with their hands frequently in water, such as dishwashers, launderers, bartenders, and homemakers. Clinical presentation most commonly consists of a central erythematous erosion surrounded by a rim of white macerated skin involving at least one interdigital web space. The differential diagnosis is narrow, consisting of irritant contact dermatitis (ICD), erythrasma, inverse psoriasis, and bacterial infection (i.e. impetigo). The diagnosis is made by clinical examination in addition to fungal culture and KOH testing. The prognosis is good and treatment options include avoidance of frequent water immersion and topical or oral antifungal agents. Suspicion for secondary infections such as erysipelas and cellulitis should remain high until lesions have resolved. This review aims to address the history, epidemiology, pathophysiology, histopathology, clinical presentation, differential diagnoses, diagnosis, prognosis, and management of EIB. It also suggests an alternative name in place of the current misnomer.


Subject(s)
Candidiasis, Cutaneous/diagnosis , Hand Dermatoses/diagnosis , Antifungal Agents/therapeutic use , Candidiasis, Cutaneous/drug therapy , Candidiasis, Cutaneous/epidemiology , Dermatitis, Irritant/diagnosis , Diabetes Mellitus/epidemiology , Diagnosis, Differential , Erythrasma/diagnosis , Hand Dermatoses/drug therapy , Hand Dermatoses/epidemiology , Humans , Impetigo/diagnosis , Occupational Exposure/statistics & numerical data , Psoriasis/diagnosis , Risk Factors , Water
18.
Article in English | MEDLINE | ID: mdl-29198783

ABSTRACT

Cutaneous infections and infestations are common among children and adolescents. Ectoparasitic infestations affect individuals across the globe. Head lice, body lice, scabies, and infestations with bed bugs are seen in individuals who reside in both resource poor areas and in developed countries. Superficial cutaneous and mucosal candida infections occur throughout the life cycle. Dermatophyte infections of keratin-containing skin and skin structures result in tinea capitis (scalp), tinea corporis (body), tinea pedis (foot), and tinea unguium (nails). Less frequent endemic fungal infections such as blastomycosis, coccidiodomycosis, and histoplasmosis may present with skin findings. This article will describe the epidemiology and transmission of these conditions as well as their clinical manifestations. The approach to diagnosis will be addressed as well as primary prevention and current therapies.


Subject(s)
Dermatomycoses/diagnosis , Skin Diseases, Parasitic/diagnosis , Adolescent , Animals , Bedbugs , Candidiasis/diagnosis , Candidiasis/epidemiology , Candidiasis/therapy , Candidiasis, Cutaneous/diagnosis , Candidiasis, Cutaneous/epidemiology , Candidiasis, Cutaneous/therapy , Child , Dermatomycoses/epidemiology , Dermatomycoses/therapy , Humans , Lice Infestations/diagnosis , Lice Infestations/epidemiology , Lice Infestations/therapy , Onychomycosis/diagnosis , Onychomycosis/epidemiology , Onychomycosis/therapy , Pediculus , Scabies/diagnosis , Scabies/epidemiology , Scabies/therapy , Scalp Dermatoses/diagnosis , Scalp Dermatoses/epidemiology , Scalp Dermatoses/parasitology , Scalp Dermatoses/therapy , Skin/microbiology , Skin/parasitology , Skin/pathology , Skin Diseases, Parasitic/epidemiology , Skin Diseases, Parasitic/therapy , Tinea/diagnosis , Tinea/epidemiology , Tinea/therapy , Tinea Capitis/diagnosis , Tinea Capitis/epidemiology , Tinea Capitis/therapy , Tinea Pedis/diagnosis , Tinea Pedis/epidemiology , Tinea Pedis/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...